Maternal and Child Health
Conditions
Brief summary
The goal of this randomized controlled trial is to see the effect of vitamin D supplementation on fetomaternal outcomes in pregnant females with Latent Tuberculosis infection The main question\[s\] it aims to answer are: If Vitamin D supplementation has any impact on maternal outcomes. If Vitamin D supplementation has any impact on fetal outcomes.
Detailed description
This study aims to see the impact of vitamin D supplementation on fetomaternal outcomes in pregnant females with latent tuberculosis infection. A three-arm (parallel) randomized controlled trial (RCT) will be conducted in a high-burden setting. A calculated sample of 99 (33 in each group) pregnant females with LTBI will be enrolled based on predefined inclusion criteria. Vitamin D supplementation will be given as per study protocols. Group-A (No intervention), Group-B (2000IU/day), Group-C (4000IU/day). To maintain the safety measures throughout the study all the study participants will be monitored for hypervitaminosis D. Informed consent will be obtained from all participants. The study will be conducted after approval by the ethical review board(s). The final analysis will be based on the effect of vitamin D supplementation on pre-defined fetomaternal outcomes.
Interventions
DIETARY_SUPPLEMENTVitamin-D supplementation
Participants receiving a daily dose of vitamin D supplementation
Sponsors
University of the Punjab
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
\- Pregnant females aged 18-35 years, already enrolled for delivery in the specified setting coming regularly for prenatal checkups with positive tuberculin skin test
Exclusion criteria
* History of active T.B * Use of any dietary supplement containing more than 400 IU/day (10 mcg/day) of vitamin D within the month before enrolment; * Presence of any confounders;
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| C/Section delivery (Maternal Outcomes) | Three months | Incidence of Caesarean delivery (% age of females having surgical delivery of baby via incision on abdomen and uterus) |
| Pre-Eclampsia (Maternal Outcome) | Three months | Incidence of Pre-eclampsia (percentage of Females having proteinuria on urine dip test with blood pressure \> 140/90 mmHg) |
| Gestational Diabetes Mellitus (Maternal Outcome) | Three months | Incidence of Gestational diabetes (percentage of females having abnormal glucose intolerance i.e. fasting glucose \> 92mg/dL, after using 75g glucose load one-hour glucose \> 180mg/dL or two-hour glucose \> 153mg/dL) |
| Apgar Score (Foetal Outcome) | One month | Apgar scores (The 10-point Apgar score has been used to assess the condition and prognosis of newborn infants throughout the world. Each of five easily identifiable characteristics i.e. heart rate, respiratory effort, muscle tone, reflex irritability, and color is assessed and assigned a value of 0 to 2. The total score is the sum of the five components, and a score of 7 or higher indicates that the baby's condition is good to excellent. The Apgar score is determined at one and five minutes after delivery and is therefore a rapid way to evaluate the physical condition of newborn infants. Of the two scores, the five-minute score has come to be regarded as the better predictor of survival in infancy.) |
| Low Birth Weight (Foetal Outcome) | One month | Incidence of low birth weight babies (percentage of neonates weighing \<2.5kg) |
| Pre-Term delivery (Foetal Outcome) | One month | Incidence of pre-term delivery (percentage of live births before 37 completed gestation weeks) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in maternal vitamin-D levels | Two-Three months | To determine whether the baseline vitamin D levels are modified by vitamin D supplementation. (Post intervention mean vitamin-D levels in ng/dl) |
Countries
Pakistan
Outcome results
None listed